Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer

por Szlosarek, Peter W., Wimalasingham, Akhila G., Phillips, Melissa M., Hall, Peter E., Chan, Pui Ying, Conibear, John, Lim, Louise, Rashid, Sukaina, Steele, Jeremy, Wells, Paula, Shiu, Chiung‐Fang, Kuo, Chih‐Ling, Feng, Xiaoxing, Johnston, Amanda, Bomalaski, John, Ellis, Stephen, Grantham, Marianne, Sheaff, Michael
Publicado 2021

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer

por Davies, Caitlin R., Guo, Tianyu, Burke, Edwina, Stankiewicz, Elzbieta, Xu, Lei, Mao, Xueying, Scandura, Glenda, Rajan, Prabhakar, Tipples, Karen, Alifrangis, Constantine, Wimalasingham, Akhila Ganeshi, Galazi, Myria, Crusz, Shanthini, Powles, Thomas, Grey, Alistair, Oliver, Tim, Kudahetti, Sakunthala, Shaw, Greg, Berney, Daniel, Shamash, Jonathan, Lu, Yong-Jie
Publicado 2023

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer

por Rose, Tracy L., Deal, Allison M., Ladoire, Sylvain, Créhange, Gilles, Galsky, Matthew D., Rosenberg, Jonathan E., Bellmunt, Joaquim, Wimalasingham, Akhila, Wong, Yu-Ning, Harshman, Lauren C., Chowdhury, Simon, Niegisch, Guenter, Liontos, Michalis, Yu, Evan Y., Pal, Sumanta K., Chen, Ronald C., Wang, Andrew Z., Nielsen, Matthew E., Smith, Angela B., Milowsky, Matthew I.
Publicado 2016